Chelation treatment is a normal way to detoxify the body of noxious substance and destructive metals. Chelation treatment involves the inoculation of ethylene thiamine tetra acetic acid (EDTA). It is a mean by which a natural material binds to minerals and ionized metals (electrically indicted) such as iron, calcium, lead, copper, etc.

The first use of Chelation is in Germany in 1930. A decade later, EDTA (ethylene thiamine tetra acetic) was utilized by some American personnel suffering from lead venomous. After several health studies, in 1950, Dr. Norman Clarke, executive of Providence Sanatorium in Detroit, Michigan, noted the therapy with EDTA, which can recover or reinstate physical condition from many ailments. These enhancements includes, but are not restricted to decrease in angina twinge, reduce skin ailments, loss and keeping a standard mass, reduce in heart disorders, developing reminiscence senses and necessity of the intelligence (sight, hearing, smell), improved vigor, etc.

In USA, the FDA as a therapy for lead venomous has permitted Chelation treatment with EDTA only. However, since heavy metals poisoning can be liable for major infections, in different treatment, it is used to treat heart infection, tumor, gangrene, thyroid turmoil's, various sclerosis, brawny dystrophy, psoriasis, diabetes, arthritis, Alzheimer's infection, and the enhancement of reminiscence, vision, perceive sound, and odor.

Chelation treatment and the Conservative Medication

In addition to the detoxification of the body, current technical studies in the conservative medication prove the optimistic results of chelation treatment in the healing of cardiovascular infections. However, many scientists yet disprove this innovation. In 2003, National foundation of physical condition has decided to take on a complete study for five years to review the efficiency of chelation treatment in more than 2 500 people surviving a heart assault. Since we are in 2008, the final year of this cram, very soon, we will have the effect. In the meantime, many patients persist to aver the reimbursement of chelation treatment in their life.

Chelation treatment and tumor

According to Journal of Advancement in Medicine, humanity from tumor was reduced 90% during an 18-year follow-up of 59 patients indulging with Calcium-EDTA. Only one of 59 treated patients died of tumor while 30 of 172 non-treated control subjects died of swelling. Demise from arteriosclerosis was also abridged. Treated patients had no indication of tumor.